Skip to main content
SpringerLink
Log in

Psychiatric Symptoms Comorbid with Neurological Syndromes

  • Chapter
  • First Online:
Book cover Inpatient Geriatric Psychiatry

  • 790 Accesses

Abstract

Psychiatric/behavioral symptoms in the context of neurological disease are particularly challenging to treat in the geriatric population. Patients with Parkinson’s disease (PD), stroke, and traumatic brain injuries (TBI), all can develop psychiatric symptoms which then interact and exacerbate their neurological symptoms. The medications prescribed to treat psychiatric symptoms can also adversely impact neurological symptoms. These interactions are further complicated by the effects of comorbid medical conditions, as well as geriatric changes in pharmacokinetics, pharmacodynamics, and excretion of medications. This chapter offers evidence-based guidelines for management of psychiatric symptoms seen in three neurological conditions common among geriatric inpatients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;23:1670–83.

    Article  CAS  Google Scholar 

  2. Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatr. 2010;55(6):341–9.

    Article  Google Scholar 

  3. Rapoport M, Verhoeff NP, Robert van Reekum MD, Loy-English I, Feldman H, Rockwood K, et al. Traumatic brain injury and dementia. Can Alzheimer Dis Rev. 2004;7(2):4–8.

    Google Scholar 

  4. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–14.

    Article  CAS  PubMed  Google Scholar 

  5. NPItest.net [Internet]. [cited March 2018 Mar 15]. Available from http://www.npitest.org/.

  6. Tarsy D. Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. JAMA. 2012;307(21):2305–231.

    Article  CAS  PubMed  Google Scholar 

  7. Borek LL, Amick MM, Friedman JH. Non-motor aspects of Parkinson’s disease. CNS Spectr. 2006;11(7):541–54.

    Article  PubMed  Google Scholar 

  8. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63(7):969–73.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Weintraub D, Koester J, Potenza MN, Siderowf AD, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589–95.

    Article  PubMed  Google Scholar 

  10. Petrovic M, Stefanova E, Ziropadia L, Stoikovic T, Kostic VS. Neuropsychiatric symptoms in Serbian patients with Parkinson’s disease. J Neurol Sci. 2016;367:342–6.

    Article  PubMed  Google Scholar 

  11. Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol. 2012;8(1):35–47.

    Article  CAS  Google Scholar 

  12. Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78(1):36–42.

    Article  CAS  PubMed  Google Scholar 

  13. Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson’s disease. CMAJ. 2006;175(12):1545–52.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Schiffer RB, Kurlan R, Rubin A, Boer S. Evidence for atypical depression in Parkinson’s disease. Am J Psychiatry. 1988;145:1020–2.

    Article  CAS  PubMed  Google Scholar 

  15. Rickards H. Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 1):i48–52.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012;78(16):1229–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bomasang-Layno E, Fadion I, Murray AN, Himelhoch S. Antidepressive treatments for Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2015;21(8):833–42.

    Article  PubMed  Google Scholar 

  18. Borisovskaya A, Bryson WC, Buchholz J, Samii A, Borson S. Electroconvulsive therapy for depression in Parkinson’s disease: systematic review of evidence and recommendations. Neurodegener Dis Manag. 2016;6(2):161–76.

    Article  PubMed  Google Scholar 

  19. Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, et al. Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson disease psychosis. JAMDA. 2015;16(10):898–917.

    PubMed  Google Scholar 

  20. Pintor L, Valldeoriola F, Baillés E, Martí MJ, Muñiz A, Tolosa E. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial. Clin Neuropharmacol. 2012;35(2):61–6.

    Article  CAS  PubMed  Google Scholar 

  21. Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):996–1002.

    Article  CAS  PubMed  Google Scholar 

  22. Weiss HD, Marsh L. Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. Neurol Clin Pract. 2012;2(4):267–74.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64(8):1089–96.

    Article  PubMed  Google Scholar 

  24. Fasano A, Ricciardi L, Pettorruso M, Bentivoglio AR. Management of punding in Parkinson’s disease: an open-label prospective study. J Neurol. 2011;258(4):656–60.

    Article  CAS  PubMed  Google Scholar 

  25. Adler CH, Thorpy MJ. Sleep issues in Parkinson’s disease. Neurology. 2005;64(Suppl 3):S12–20.

    Article  PubMed  Google Scholar 

  26. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2005;20(10):1255–63.

    Article  PubMed  Google Scholar 

  27. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10(3):314–9.

    Article  CAS  PubMed  Google Scholar 

  28. Angelelli P, Paolucci S, Bivona U, Piccardi L, Ciurli P, Cantagallo A, et al. Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatr Scand. 2004;110:55–63.

    Article  CAS  PubMed  Google Scholar 

  29. Ayerbe L, Ayis S, Wolfe CDA, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry. 2013;202:14.

    Article  PubMed  Google Scholar 

  30. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:1330–40.

    Article  PubMed  Google Scholar 

  31. Lipsey JR, Spencer WC, Rabins PV, Robinson RG. Phenomenological comparison of functional and post-stroke depression. Am J Psychiatry. 1986;143:527–9.

    Article  CAS  PubMed  Google Scholar 

  32. Tang WK, Chen YK, Mok V, Chu WC, Ungvari GS, Ahuja AT, Wong KS. Acute basal ganglia infarcts in poststroke fatigue: an MRI study. J Neurol. 2010;257:178–82.

    Article  PubMed  Google Scholar 

  33. Robinson RG. The clinical neuropsychiatry of stroke. 2nd ed. Cambridge (UK): Cambridge University Press; 2006.

    Book  Google Scholar 

  34. Eskes GA, Lanctôt KL, Herrmann N, Lindsay P, Bayley M, Bouvier L, et al. Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke practice guidelines, update 2015. Int J Stroke. 2015;10(7):1130–40.

    Article  PubMed  Google Scholar 

  35. Leeds L, Meara RJ, Hobson JP. The utility of the Stroke Aphasia Depression Questionnaire (SADQ) in a stroke rehabilitation unit. Clin Rehabil. 2004;18(2):228–31.

    Article  CAS  PubMed  Google Scholar 

  36. Robinson RG, Bolla-Wilson K, Kaplan E, Lipsey JR, Price TR. Depression influences intellectual impairment in stroke patients. Br J Psychiatry. 1986;148:541–7.

    Article  CAS  PubMed  Google Scholar 

  37. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev [Internet]. 2008 [cited 2017 Dec 07]; 3. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003689.pub3/abstract.

  38. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008, Issue 4. Art. No.: CD003437. DOI: https://doi.org/10.1002/14651858.CD003437.pub3.

  39. Karaiskos D, Tzavellas E, Spengos K, Vassilopoulou S, Paparrigopouls T. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue. J Neuropsychiatry Clin Neurosci. 2012;24(3):349–53.

    Article  CAS  PubMed  Google Scholar 

  40. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil. 1998;79(9):1047–50.

    Article  CAS  PubMed  Google Scholar 

  41. Towfighi A, Ovbiagele B, El Husseini N, Hackett ML, Jorge RE, Kissela BM, et al. Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(2):30–43.

    Article  Google Scholar 

  42. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry. 1986;47(5):258–60.

    CAS  PubMed  Google Scholar 

  43. Ferro JM, Caeiro L, Santos C. Poststroke emotional and behavior impairment: a narrative review. Cerebrovasc Dis. 2009;27(suppl):197–203.

    Article  PubMed  Google Scholar 

  44. Santos CO, Caeiro L, Ferro JM, Figueira ML. Mania and stroke: a systematic review. Cerebrovasc Dis. 2011;32:11–21.

    Article  PubMed  Google Scholar 

  45. Schottke H, Giabbiconi CM. Post-stroke depression and post-stroke anxiety: prevalence and predictors. Int Psychogeriatr. 2015;27(11):1805–12.

    Article  PubMed  Google Scholar 

  46. Wright F, Wu S, Ho-Yan YC, Mead G. Factors associated with post-stroke anxiety: a systematic review and meta-analysis. Stroke Res Treat [Internet]. 2017 Feb [cited 2017 Dec 05]; 2017:7. Available from: doi:https://doi.org/10.1155/2017/2124743.

    Article  Google Scholar 

  47. van Dalen JW, Moll van Charante EP, Nederkoorn PJ, van Gool WA, Richard E. Poststroke apathy. Stroke. 2013;44:851–60.

    Article  PubMed  Google Scholar 

  48. Okada K, Kobayashi S, Aoki K, et al. Assessment of motivational less in poststroke patients using the Japanese version of Starkstein’s Apathy Scale. Nosotchu. 1998;20:318–23. (in Japanese).

    Article  Google Scholar 

  49. Sama S, Yamashita H, Shigenobu M, Watanabe A, Hiramoto K, Kurisu K, et al. Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry. 2007;22:1046–51.

    Article  Google Scholar 

  50. Sami MB, Faruqui R. The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke. Acta Neuropsychiatr. 2015;27(6):317–26.

    Article  PubMed  Google Scholar 

  51. Delbari A, Salman-Roghani R, Lokk J. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. Eur Neurol. 2011;66:7–13.

    Article  CAS  PubMed  Google Scholar 

  52. Kohno N, Abe S, Toyoda G, Oguro H, Bokura H, Yamaguchi S. Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole. J Clin Neurosci. 2010;17(6):804–6.

    Article  CAS  PubMed  Google Scholar 

  53. Gillespie DC, Cadden AP, Lees R, West RM, Broomfield NM. Prevalence of pseudobulbar affect following stroke: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2016;25(3):688–94.

    Article  PubMed  Google Scholar 

  54. Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Stroke. 2010;41(7):e460–1.

    Article  Google Scholar 

  55. Levin DN, Finklestein S. Delayed psychosis after right temporoparietal stroke or trauma: relation to epilepsy. Neurology. 1982;32:267–73.

    Article  Google Scholar 

  56. Levin DN, Grek A. The anatomic basis of delusions after right cerebral infarction. Neurology. 1984;34:577–82.

    Article  Google Scholar 

  57. Stone J, Townend E, Kwan J, Haga K, Dennis MS, Sharpe M. Personality change after stroke: some preliminary observations. J Neurol Neurosurg Psychiatry. 2004;75(12):1708–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Kim JS, Choi S, Kwon SU, Seo YS. Inability to control anger or aggression after stroke. Neurology. 2002;58(7):1106–8.

    Article  CAS  PubMed  Google Scholar 

  59. Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG. Aggressive behaviour in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Arch Phys Med Rehabil. 2006;87(6):793–8.

    Article  PubMed  Google Scholar 

  60. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290:1906–14.

    Article  CAS  PubMed  Google Scholar 

  61. Harbison J, Ford GA, James OF, Gibson GJ. Sleep-disordered breathing following acute stroke. QJM. 2002;95(11):741–7.

    Article  CAS  PubMed  Google Scholar 

  62. Janssens JP, Pautex S, Hilleret H, et al. Sleep disordered breathing in the elderly. Aging. 2000;12:417–29.

    CAS  PubMed  Google Scholar 

  63. Perry L, Mclaren S. An exploration of nutrition and eating disabilities in relation to quality of life at 6 months poststroke. Health Soc Care Community. 2004;12(4):288–97.

    Article  PubMed  Google Scholar 

  64. Ciurli P, Formisano R, Bivona U, Cantagallo A, Angelelli P. Neuropsychiatric disorders in persons with severe traumatic brain injury: prevalence, phenomenology, and relationship with demographic, clinical, and functional features. J Head Trauma Rehabil. 2011;26(2):116–26.

    Article  PubMed  Google Scholar 

  65. Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S. Major depression following traumatic brain injury. Arch Gen Psychiatry. 2004;61(1):42–50.

    Article  PubMed  Google Scholar 

  66. Kim JK, Kim NY, Kim YW. Predictors for depressive mood in geriatric patients after traumatic brain injury: a retrospective cross-sectional study. Ann Rehabil Med. 2017;41(2):279–89.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Ontario Neurotrauma Foundation. Guidelines for concussion/mild traumatic brain injury & persistent symptoms [Internet]. Ontario: the Foundation; 2013 [Accessed Dec 03 2017]. Available from: http://onf.org/system/attachments/223/original/ONF_mTBI_Guidelines_2nd_Edition_COMPLETE.pdf.

  68. Jorge RE, Acion L, Burin DI, Robinson RG. Sertraline for preventing mood disorders following traumatic brain injury: a randomized clinical trial. JAMA Psychiat. 2016;73(10):1041–7.

    Article  Google Scholar 

  69. Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry. 2009;166(6):653–61.

    Article  PubMed  Google Scholar 

  70. Soo C, Tate RL. Psychological treatment for anxiety in people with traumatic brain injury. Cochrane Database Syst Rev [Internet]. 2007 [cited 201e: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005239.pub2/abstract .

  71. Lane-Brown A, Tate R. Interventions for apathy after traumatic brain injury. Cochrane Database Syst Rev [Internet]. 2009 [cited 2017 Dec 10]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006341.pub2/abstract .

  72. Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS. Comparing effect of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol. 2005;20(2):97–104.

    Article  CAS  PubMed  Google Scholar 

  73. McAllister TW, Ferrell RB. Evaluation and treatment of psychosis after traumatic brain injury. NeuroRehabilitation. 2002;17:357–68.

    PubMed  Google Scholar 

  74. Tateno A, Jorge RE, Robinson RG. Clinical correlates of aggressive behaviour after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2003;15:155–60.

    Article  PubMed  Google Scholar 

  75. Klages J, Dagg P. Aggression and brain injury. In: Hurwitz TA, Lee WT, editors. Casebook of neuropsychiatry. Washington, DC: American Psychiatric Publishing; 2013. p. 24–31.

    Google Scholar 

  76. Castriotta RJ, Wilde MC, Lai JM, Atanasov S, et al. Prevalence and consequences of sleep disorders in traumatic brain injury. J Clin Sleep Med. 2007;3(4):349–56.

    PubMed  PubMed Central  Google Scholar 

  77. Ouellet MC, Beaulieu-Bonneau S, Morin CM. Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors. J Head Trauma Rehabil. 2006;21(3):199–212.

    Article  PubMed  Google Scholar 

  78. Castriotta RJ, Atanasov S, Wilde MC, Masel BE, et al. Treatment of sleep disorders after traumatic brain injury. J Clin Sleep Med. 2009;5(2):137.

    PubMed  PubMed Central  Google Scholar 

  79. Uher R, Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry. 2005;76:852–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Perry DC, Sturm VE, Peterson MJ, Pieper CF, Bullock T, Boeve BF, et al. Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. J Neurosurg. 2016;124(2):511–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London Health Sciences Centre, London, ON, Canada

    Elyse Ross & Shaji Khan

  2. Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, St. Joseph’s Health Care London/Parkwood Institute Mental Health Care Building, London, ON, Canada

    Amer M. Burhan

Authors
  1. Elyse Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaji Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amer M. Burhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amer M. Burhan .

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Stanford/VA Alzheimer’s Center, VA Health Care System, Palo Alto, CA, USA

    Howard H. Fenn

  2. Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada

    Ana Hategan

  3. Department of Psychiatry, Baylor Scott and White Central Texas, Division College of Medicine, Texas A & M University, Health Science Center, Temple, TX, USA

    James A. Bourgeois

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ross, E., Khan, S., Burhan, A.M. (2019). Psychiatric Symptoms Comorbid with Neurological Syndromes. In: Fenn, H., Hategan, A., Bourgeois, J. (eds) Inpatient Geriatric Psychiatry . Springer, Cham. https://doi.org/10.1007/978-3-030-10401-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10401-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10400-9

  • Online ISBN: 978-3-030-10401-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation